Dr. Neville S. Wilson. – 15 July 2007. The widely held belief that blood cholesterol levels are potentially harmful and should be lowered in order to prevent heart disease is a product of speculative and persuasive promotion by advocates of what has been called the…
(originally published Feb 1st 2011) The traditional approach to the management of obesity has been the recommendation to “diet and exercise”, and to elicit the support of family doctors with aims to modify unhealthy lifestyle habits. The limited success of such conventional strategies is clearly…
While the health benefits of poly-unsaturated fatty acids (PUFA) omega-3 have been well established for the past three decades, it is only recently, since its appearance as a pharmaceutical agent, that this remarkable fish oil product has received recognition for its usefulness as a preventive…
While no one can predict with certainty what the span of your life may be, there is new scientific evidence to support a choice that will increase very significantly your best chance of a long survival. Unsuspecting and unpredicted events are an ever present threat…
Is it Justifiable to Medicalise Healthy Persons? (THE JUPITER STUDY 2008) A recent ruling by the FDA (Dec 2009) permitted new criteria for the use of the cholesterol lowering drug, CRESTOR (rosuvastatin), thereby sanctioning its use as a preventative agent for healthy persons who may be…
THE DILEMMA: The Fluoride dilemma is not new and continues to extract comments and recommendations from responsible bodies who question the safety and wisdom of public water fluoridation. The proponents of fluoridation, on the other hand, continue to promote the image of safety and benefits…
The long awaited results, of what has become a controversial drug trial, were announced recently, generating intense debate in medical circles, evoking widespread media speculation, and eliciting critical comments from the chair of the USA House of Representatives. Controversies arising in the wake of…
by Dr. Neville Wilson The long awaited results, of what has become a controversial drug trial, were announced recently, generating intense debate in medical circles, evoking widespread media speculation, and eliciting critical comments from the chair of the USA House of Representatives. Controversies arising in…
The review and revision of Clinical Guidelines for purposes of risk stratifying and risk reduction in cardiovascular disease prevention is an ongoing challenge and current initiatives focus on their implications for primary care providers. The AHA guidelines for 2007 offer a timely and broader…